Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Dissecting the Genetic Complexity of Fusarium Crown Rot Resistance in Wheat.

Pariyar SR, Erginbas-Orakci G, Dadshani S, Chijioke OB, Léon J, Dababat AA, Grundler FMW.

Sci Rep. 2020 Feb 21;10(1):3200. doi: 10.1038/s41598-020-60190-4.

2.

Erratum for Murer et al., "MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo".

Murer A, Rühl J, Zbinden A, Capaul R, Hammerschmidt W, Chijioke O, Münz C.

mBio. 2019 Jul 23;10(4). pii: e01482-19. doi: 10.1128/mBio.01482-19. No abstract available.

3.

Infection and immune control of human oncogenic γ-herpesviruses in humanized mice.

McHugh D, Caduff N, Murer A, Engelmann C, Deng Y, Zdimerova H, Zens K, Chijioke O, Münz C.

Philos Trans R Soc Lond B Biol Sci. 2019 May 27;374(1773):20180296. doi: 10.1098/rstb.2018.0296.

PMID:
30955487
4.

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo.

Murer A, Rühl J, Zbinden A, Capaul R, Hammerschmidt W, Chijioke O, Münz C.

mBio. 2019 Jan 15;10(1). pii: e01941-18. doi: 10.1128/mBio.01941-18. Erratum in: mBio. 2019 Jul 23;10(4):.

5.

EBV persistence without its EBNA3A and 3C oncogenes in vivo.

Murer A, McHugh D, Caduff N, Kalchschmidt J, Barros M, Zbinden A, Capaul R, Niedobitek G, Allday M, Chijioke O, Münz C.

PLoS Pathog. 2018 Apr 30;14(4):e1007039. doi: 10.1371/journal.ppat.1007039. eCollection 2018 Apr.

6.

Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells.

Raykova A, Carrega P, Lehmann FM, Ivanek R, Landtwing V, Quast I, Lünemann JD, Finke D, Ferlazzo G, Chijioke O, Münz C.

Blood Adv. 2017 Dec 14;1(27):2679-2691. doi: 10.1182/bloodadvances.2017008839. eCollection 2017 Dec 26.

7.

Investigation into Hypoglycemic, Antihyperlipidemic, and Renoprotective Potentials of Dennettia tripetala (Pepper Fruit) Seed in a Rat Model of Diabetes.

Anioke I, Okwuosa C, Uchendu I, Chijioke O, Dozie-Nwakile O, Ikegwuonu I, Kalu P, Okafor M.

Biomed Res Int. 2017;2017:6923629. doi: 10.1155/2017/6923629. Epub 2017 Oct 17.

8.

Natural killer cells in herpesvirus infections.

Münz C, Chijioke O.

F1000Res. 2017 Jul 26;6. pii: F1000 Faculty Rev-1231. doi: 10.12688/f1000research.11197.1. eCollection 2017. Review.

9.

An immunocompetent patient with a recurrence-free Epstein-Barr virus positive plasmacytoma possesses robust Epstein-Barr virus specific T-cell responses.

Chatterjee B, Sahli L, Chijioke O, Went P, Münz C, Trojan A.

Haematologica. 2017 Oct;102(10):e419-e422. doi: 10.3324/haematol.2017.172791. Epub 2017 Jul 13. No abstract available.

10.

Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.

Ferreira-Teixeira M, Paiva-Oliveira D, Parada B, Alves V, Sousa V, Chijioke O, Münz C, Reis F, Rodrigues-Santos P, Gomes C.

BMC Med. 2016 Oct 21;14(1):163.

11.

NK Cell Influence on the Outcome of Primary Epstein-Barr Virus Infection.

Chijioke O, Landtwing V, Münz C.

Front Immunol. 2016 Aug 29;7:323. doi: 10.3389/fimmu.2016.00323. eCollection 2016. Review.

12.

Cognate HLA absence in trans diminishes human NK cell education.

Landtwing V, Raykova A, Pezzino G, Béziat V, Marcenaro E, Graf C, Moretta A, Capaul R, Zbinden A, Ferlazzo G, Malmberg KJ, Chijioke O, Münz C.

J Clin Invest. 2016 Oct 3;126(10):3772-3782. doi: 10.1172/JCI86923. Epub 2016 Aug 29.

13.

Availability and functionality of sphygmomanometers at health care institutions in Enugu, Nigeria.

Chijioke CP, Okolo TO, Nwadike KI, Ejim EC, Ekochin FC, Aronu GN, Ghasi SI, Chijioke OU.

Niger J Clin Pract. 2015 Jul-Aug;18(4):544-7. doi: 10.4103/1119-3077.156899.

14.

Hepatitis e virus detection in liver tissue from patients with suspected drug-induced liver injury.

Chijioke O, Bawohl M, Springer E, Weber A.

Front Med (Lausanne). 2015 Mar 30;2:20. doi: 10.3389/fmed.2015.00020. eCollection 2015.

15.

Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components.

Chijioke O, Marcenaro E, Moretta A, Capaul R, Münz C.

J Infect Dis. 2015 Sep 1;212(5):803-7. doi: 10.1093/infdis/jiv114. Epub 2015 Feb 26.

16.

Role for early-differentiated natural killer cells in infectious mononucleosis.

Azzi T, Lünemann A, Murer A, Ueda S, Béziat V, Malmberg KJ, Staubli G, Gysin C, Berger C, Münz C, Chijioke O, Nadal D.

Blood. 2014 Oct 16;124(16):2533-43. doi: 10.1182/blood-2014-01-553024. Epub 2014 Sep 9.

17.

Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.

Antsiferova O, Müller A, Rämer PC, Chijioke O, Chatterjee B, Raykova A, Planas R, Sospedra M, Shumilov A, Tsai MH, Delecluse HJ, Münz C.

PLoS Pathog. 2014 Aug 28;10(8):e1004333. doi: 10.1371/journal.ppat.1004333. eCollection 2014 Aug.

18.

Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance.

Jandus C, Boligan KF, Chijioke O, Liu H, Dahlhaus M, Démoulins T, Schneider C, Wehrli M, Hunger RE, Baerlocher GM, Simon HU, Romero P, Münz C, von Gunten S.

J Clin Invest. 2014 Apr;124(4):1810-20. doi: 10.1172/JCI65899. Epub 2014 Feb 24.

19.

Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection.

Chijioke O, Müller A, Feederle R, Barros MH, Krieg C, Emmel V, Marcenaro E, Leung CS, Antsiferova O, Landtwing V, Bossart W, Moretta A, Hassan R, Boyman O, Niedobitek G, Delecluse HJ, Capaul R, Münz C.

Cell Rep. 2013 Dec 26;5(6):1489-98. doi: 10.1016/j.celrep.2013.11.041. Epub 2013 Dec 19. Erratum in: Cell Rep. 2015 Aug 4;12(5):901.

20.

Dendritic cell derived cytokines in human natural killer cell differentiation and activation.

Chijioke O, Münz C.

Front Immunol. 2013 Nov 11;4:365. doi: 10.3389/fimmu.2013.00365. eCollection 2013. Review.

21.

Infectious diseases in humanized mice.

Leung C, Chijioke O, Gujer C, Chatterjee B, Antsiferova O, Landtwing V, McHugh D, Raykova A, Münz C.

Eur J Immunol. 2013 Sep;43(9):2246-54. doi: 10.1002/eji.201343815. Review.

22.

Innate immune responses against Epstein Barr virus infection.

Chijioke O, Azzi T, Nadal D, Münz C.

J Leukoc Biol. 2013 Dec;94(6):1185-90. doi: 10.1189/jlb.0313173. Epub 2013 Jun 28. Review.

23.

Interactions of human myeloid cells with natural killer cell subsets in vitro and in vivo.

Chijioke O, Münz C.

J Biomed Biotechnol. 2011;2011:251679. doi: 10.1155/2011/251679. Epub 2011 Mar 31. Review.

24.

Mice with human immune system components as in vivo models for infections with human pathogens.

Rämer PC, Chijioke O, Meixlsperger S, Leung CS, Münz C.

Immunol Cell Biol. 2011 Mar;89(3):408-16. doi: 10.1038/icb.2010.151. Epub 2011 Feb 8. Review.

25.

Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence.

Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Rämer PC, Ferlazzo G, Münz C.

Blood. 2010 Nov 18;116(20):4158-67. doi: 10.1182/blood-2010-02-270678. Epub 2010 Jul 29.

26.

A vaccine against Helicobacter pylori: towards understanding the mechanism of protection.

Aebischer T, Walduck A, Schroeder J, Wehrens A, Chijioke O, Schreiber S, Meyer TF.

Int J Med Microbiol. 2008 Jan;298(1-2):161-8. Epub 2007 Aug 16. Review.

PMID:
17702653

Supplemental Content

Loading ...
Support Center